May 8, 2026 · Form 4 insider transaction
Kemps-Polanco Reshema bought 1,438 shares of Charles River Laboratories International, Inc. at $177.62 per share, a transaction worth $255.4K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders.